Isorhamnetin inhibits hypertrophic scar formation through TGF-β1/Smad and TGF-β1/CREB3L1 signaling pathways
Article in Heliyon (June 2024)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Article in Heliyon (June 2024)
Article in The Yale Journal of Biology and Medicine (December 2023)
Article in Frontiers in Immunology (June 2023)